Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PIK3C2A inhibitors(phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC30H29N7O3S2 |
InChIKeyWBXQHPRLMAYBJC-UHFFFAOYSA-N |
CAS Registry- |